Hinge Health (HNGE) president relinquishes shares to cover RSU tax withholding

Rhea-AI Filing Summary

Hinge Health, Inc. President James Pursley reported a routine tax-related share disposition tied to restricted stock unit vesting. On the transaction date, 831 shares of Class A Common Stock were relinquished and cancelled at an indicated price of $44.60 per share to cover federal and state tax withholding obligations.

The footnote explains this exempt transaction under Section 16b-3(e) was a payment of tax liability by delivering or withholding securities, not an open-market sale. Following the withholding and cancellation, Pursley directly holds 730,442 shares of Class A Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pursley James

Role President

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock	831	$44.60	$37K

Holdings After Transaction: Class A Common Stock — 730,442 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares disposed for tax withholding: 831 shares Indicated price per share: $44.60 per share Shares held after transaction: 730,442 shares

3 metrics

Shares disposed for tax withholding 831 shares Relinquished and cancelled to cover RSU tax obligations

Indicated price per share $44.60 per share Value used for the 831-share tax-withholding disposition

Shares held after transaction 730,442 shares Direct holdings of Class A Common Stock following the Form 4 transaction

Key Terms

restricted stock units, Section 16b-3(e), tax withholding obligations

3 terms

restricted stock units financial

"resulting from the vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Section 16b-3(e) regulatory

"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price"

tax withholding obligations financial

"pay federal and state tax withholding obligations of the Reporting Person"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/01/2026		F(1)		831	D	$44.6	730,442	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

	/s/ James Budge, Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Hinge Health (HNGE) report for President James Pursley?

Hinge Health reported that President James Pursley relinquished 831 shares of Class A Common Stock. The shares were cancelled to satisfy tax withholding obligations arising from the vesting of restricted stock units, rather than being sold in the open market.

Was the HNGE Form 4 transaction by James Pursley an open-market sale of shares?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld and cancelled by Hinge Health to cover Pursley’s federal and state tax liabilities from restricted stock unit vesting.

How many Hinge Health (HNGE) shares were involved in James Pursley’s tax-withholding transaction?

The filing reports 831 shares of Hinge Health Class A Common Stock were disposed of. These shares were relinquished and cancelled in exchange for the company paying James Pursley’s associated tax withholding obligations on vested restricted stock units.

How many Hinge Health (HNGE) shares does James Pursley hold after this Form 4 transaction?

After the reported tax-withholding disposition, James Pursley directly holds 730,442 shares of Hinge Health Class A Common Stock. This indicates the transaction affected only a small portion of his overall reported shareholdings.

Why is the HNGE Form 4 transaction classified under Section 16b-3(e)?

The footnote states the transaction is exempt under Section 16b-3(e). It represents payment of exercise price or tax liability by delivering or withholding securities in connection with the vesting of restricted stock units issued under Rule 16b-3.